These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 20795971

  • 1. S-phase fraction and DNA ploidy in oral leukoplakia.
    Khanna R, Agarwal A, Khanna S, Basu S, Khanna AK.
    ANZ J Surg; 2010; 80(7-8):548-51. PubMed ID: 20795971
    [Abstract] [Full Text] [Related]

  • 2. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders.
    Sperandio M, Brown AL, Lock C, Morgan PR, Coupland VH, Madden PB, Warnakulasuriya S, Møller H, Odell EW.
    Cancer Prev Res (Phila); 2013 Aug; 6(8):822-31. PubMed ID: 23761273
    [Abstract] [Full Text] [Related]

  • 3. Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia.
    Sudbø J, Bryne M, Johannessen AC, Kildal W, Danielsen HE, Reith A.
    J Pathol; 2001 Jul; 194(3):303-10. PubMed ID: 11439362
    [Abstract] [Full Text] [Related]

  • 4. DNA ploidy in proliferative verrucous leukoplakia.
    Klanrit P, Sperandio M, Brown AL, Shirlaw PJ, Challacombe SJ, Morgan PR, Odell EW.
    Oral Oncol; 2007 Mar; 43(3):310-6. PubMed ID: 16931117
    [Abstract] [Full Text] [Related]

  • 5. Prognostic Implications of DNA Repair, Ploidy and Telomerase in the Malignant Transformation Risk Assessment of Leukoplakia.
    Thomas G, Tr S, George S P, Somanathan T, Sarojam S, Krishnankutti N, Sreedharan H, Ankathil R.
    Asian Pac J Cancer Prev; 2020 Feb 01; 21(2):309-316. PubMed ID: 32102504
    [Abstract] [Full Text] [Related]

  • 6. [The malignant transformation of leukoplakia of the oral cavity. A review of the literature and clinical case reports].
    Colella G, De Luca F, Lanza A, Tartaro GP.
    Minerva Stomatol; 1995 Jun 01; 44(6):291-300. PubMed ID: 7476784
    [Abstract] [Full Text] [Related]

  • 7. Inherited proliferative oral disorder: a reductionist approach to proliferative verrucous leukoplakia.
    Radhakrishnan R.
    Indian J Dent Res; 2011 Jun 01; 22(3):365-6. PubMed ID: 22048571
    [No Abstract] [Full Text] [Related]

  • 8. [Diagnosis and treatment of oral precancerous lesions].
    Sudbø J, Warloe T, Aamdal S, Reith A, Bryne M.
    Tidsskr Nor Laegeforen; 2001 Oct 30; 121(26):3066-71. PubMed ID: 11757442
    [Abstract] [Full Text] [Related]

  • 9. Field effect in oral precancer as assessed by DNA flow cytometry and array-CGH.
    Pentenero M, Donadini A, Di Nallo E, Maffei M, Marino R, Familiari U, Castagnola P, Gandolfo S, Giaretti W.
    J Oral Pathol Med; 2012 Feb 30; 41(2):119-23. PubMed ID: 21950471
    [Abstract] [Full Text] [Related]

  • 10. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
    Schepman KP, van der Meij EH, Smeele LE, van der Waal I.
    Oral Oncol; 1998 Jul 30; 34(4):270-5. PubMed ID: 9813722
    [Abstract] [Full Text] [Related]

  • 11. High incidence of DNA ploidy abnormalities and increased Mcm2 expression may predict malignant change in oral proliferative verrucous leukoplakia.
    Gouvêa AF, Santos Silva AR, Speight PM, Hunter K, Carlos R, Vargas PA, de Almeida OP, Lopes MA.
    Histopathology; 2013 Mar 30; 62(4):551-62. PubMed ID: 23347057
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of DNA ploidy status in patients with oral leukoplakia.
    Bremmer JF, Brakenhoff RH, Broeckaert MA, Beliën JA, Leemans CR, Bloemena E, van der Waal I, Braakhuis BJ.
    Oral Oncol; 2011 Oct 30; 47(10):956-60. PubMed ID: 21880540
    [Abstract] [Full Text] [Related]

  • 13. [Molecular risk markers for malignant transformation of oral mucosal leukoplakia ].
    Skorodumova LO, Muriaev AA, Volodina EV, Ivanov SIu, Gnuchev NV, Georgiev GP, Larin SS.
    Vopr Onkol; 2012 Oct 30; 58(3):327-32. PubMed ID: 22888646
    [No Abstract] [Full Text] [Related]

  • 14. Flow cytometric analysis of nuclear DNA content in oral leukoplakia: relation to clinicopathologic findings.
    Saito T, Yamashita T, Notani K, Fukuda H, Mizuno S, Shindoh M, Amemiya A.
    Int J Oral Maxillofac Surg; 1995 Feb 30; 24(1 Pt 1):44-7. PubMed ID: 7782640
    [Abstract] [Full Text] [Related]

  • 15. [Review of the literature on the possibility of malignant transformation of oral leukoplakia].
    Tartaro S, Colella G, Cuomo E, Giudice M.
    Stomatol Mediterr; 1986 Feb 30; 6(3):313-24. PubMed ID: 3538441
    [No Abstract] [Full Text] [Related]

  • 16. Malignant transformation of leukoplakia three times in period of 11-years--case report.
    Amino K, Tsubakimoto Y, Doi T, Sakuda M.
    J Osaka Univ Dent Sch; 1995 Dec 30; 35():13-20. PubMed ID: 9206463
    [Abstract] [Full Text] [Related]

  • 17. [Leukoplakia of the oral cavity and the real possibility of malignant transformation].
    Palattella G, Mangani F, Palattella L, Caruso F, Palattella P.
    Stomatol Mediterr; 1985 Dec 30; 5(2):181-93. PubMed ID: 3868075
    [No Abstract] [Full Text] [Related]

  • 18. DNA cytometry of oral leukoplakia and oral lichen planus.
    Femiano F, Scully C.
    Med Oral Patol Oral Cir Bucal; 2005 Apr 01; 10 Suppl 1():E9-14. PubMed ID: 15800471
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Proliferative verrucous leukoplakia and field cancerization: report of a case.
    Feller L, Wood NH, Raubenheimer EJ.
    J Int Acad Periodontol; 2006 Apr 01; 8(2):67-70. PubMed ID: 16623182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.